MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
10.90
-1.18 (-9.73%)
May 6, 2025, 4:00 PM EDT - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $364.16 million as of May 6, 2025.
Market Cap
364.16M
Enterprise Value
102.18M
1-Year Change
n/a
Ranking
Category
Stock Price
10.90
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $364.16M, a decrease of -28.55%. That is a compound annual growth rate of -40.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2025 | 403.43M | -34.50% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |